This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Alzheimer's Disease
and you are
over 18
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The primary objective is to assess the safety and tolerability of a single oral dose of BMS-708163 in healthy young male subjects and in elderly male and female subjects.

Provided treatments

  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: BMS-708163 (Gamma-Secretase Inhibitor)
  • Drug: Placebo matching BMS-708163
  • Drug: Placebo matching BMS-708163

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01454115. The sponsor of the trial is Bristol-Myers Squibb and it is looking for 116 volunteers for the current phase.
Official trial title:
Placebo-Controlled, Ascending Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-708163 in Healthy Male Subjects and a Comparison to Elderly Male and Female Subjects